GlassScriptPhysician profile
Katherine Lindley
NPI 1518338714
$3,544.05
in general payments reported to CMS, 2019-2025
19 companies · $799 in 2025
The $799 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $265 · 2022: $143 · 2023: $587 · 2024: $1,750 · 2025: $799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,135.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $529.92 | 2023-2025 | Descovy, Biktarvy, Livdelzi |
| Genzyme Corporation | $442.76 | 2024 | |
| Amgen INC. | $383.78 | 2023-2024 | Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $306.64 | 2021-2024 | Airsupra |
| Teva Pharmaceuticals USA, INC. | $233.35 | 2024 | Austedo Xr |
| Corcept Therapeutics | $227.29 | 2024 | Korlym |
| Tris Pharma INC | $211.13 | 2025 | Dyanavel Xr, Quillichew Er, Quillivant |
| Averitas Pharma INC. | $149.98 | 2025 | Qutenza |
| Abbvie INC. | $124.99 | 2021 | |
| Boston Scientific Corporation | $124.18 | 2025 | Watchman Flx |
| Neurocrine Biosciences, INC. | $123.38 | 2022 | |
| Inspire Medical Systems, INC. | $121.66 | 2023 | Inspire |
| Horizon Therapeutics Plc | $119.11 | 2023 | Krystexxa |
| Takeda Pharmaceuticals U.S.A., INC. | $115.36 | 2023 | Gammagard |
| Viiv Healthcare Company | $112.88 | 2025 | Apretude |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $94.39 | 2025 | Attruby |
| Biosense Webster, INC. | $79.50 | 2024 | Carto 3 |
| Merz North America, INC. | $23.83 | 2021 | |
| Allergan, INC. | $19.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Lindley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.